Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical PRP for Refractory Interstitial Cystitis
NCT03104361Phase 1Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Apr 2017
- Primary completion
- Jun 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet-rich plasma in interstitial cystitis (IC), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: O'Leary-Sant Symptom Score at 6 months. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT03104361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104361.